These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6868097)

  • 21. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
    Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z
    Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further-attenuated measles vaccine: characteristics and use.
    Krugman S
    Rev Infect Dis; 1983; 5(3):477-81. PubMed ID: 6879002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A minimum age for measles vaccine administration to coloured children.
    Dick B; Smith T; Kipps A
    S Afr Med J; 1975 Nov; 49(47):1951-4. PubMed ID: 1198225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trial of a reduced dose of measles vaccine in Nigerian children.
    Wallace RB; Landrigan PJ; Smith EA; Pifer J; Teller B; Foster SO
    Bull World Health Organ; 1976; 53(4):361-4. PubMed ID: 1086728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measles Vaccine.
    Griffin DE
    Viral Immunol; 2018 Mar; 31(2):86-95. PubMed ID: 29256824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of measles inoculations in the Hungarian People's Republic].
    Erdös L
    Tr Inst Im Pastera; 1979; 53():19-25. PubMed ID: 262709
    [No Abstract]   [Full Text] [Related]  

  • 28. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.
    Sangkawibha N; Ueda S; Tuchinda P; Sakuntanaga P; Sunthonsaratul A
    Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209
    [No Abstract]   [Full Text] [Related]  

  • 31. Measles: old vaccines, new vaccines.
    Griffin DE; Pan CH
    Curr Top Microbiol Immunol; 2009; 330():191-212. PubMed ID: 19203111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A trial of the intranasal vaccination of adults against measles: the approaches to an alternative revaccination method].
    Liashenko VA; Iuminova NV; Krasnova VP
    Vopr Virusol; 1992; 37(2):107-9. PubMed ID: 1441428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Safety and immunogenicity of measles attenuated live vaccine prepared by master seed lot vaccine of Shanghai-191 strain].
    Zhang SJ; Xiao QY; Li FJ
    Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):423-5. PubMed ID: 20084967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroconversion following measles immunisation.
    Swami SS; Chandra S; Dudani IU
    J Commun Dis; 1987 Jun; 19(2):141-5. PubMed ID: 3454353
    [No Abstract]   [Full Text] [Related]  

  • 35. Chorioallantoic membrane measles: development and clinical evaluation of a new further attenuated measles vaccine.
    Cerini CP; Arguedas J; Hernandez G; Frickey P; Douglas AV
    Appl Microbiol; 1974 Apr; 27(4):763-6. PubMed ID: 4856949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low seroconversion rates to measles vaccine among children in Nigeria.
    Adu FD; Akinwolere OA; Tomori O; Uche LN
    Bull World Health Organ; 1992; 70(4):457-60. PubMed ID: 1394778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The timing of tuberculin tests in relation to immunization with live viral vaccines.
    Brickman HF; Beaudry PH; Marks MI
    Pediatrics; 1975 Mar; 55(3):392-6. PubMed ID: 1143978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. II. Primary and secondary immunological response of experimental animals to attenuated and nonattenuated measles virus.
    Aleksandrowicz J; Polna I; Sadowski W
    Acta Microbiol Pol A; 1973; 5(3):139-45. PubMed ID: 4203633
    [No Abstract]   [Full Text] [Related]  

  • 39. Simultaneous administration of live attenuated measles vaccine with DTP vaccine.
    McBean AM; Gateff C; Manclark CR; Foster SO
    Pediatrics; 1978 Sep; 62(3):288-93. PubMed ID: 704197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.